Exon 3 was replaced with a modified exon containing the nucleotide substitution (AC to CT) and results in the amino acid substitution of alanine for aspartic acid at position 368 (D368A). Flp-mediated recombination removed the FRT-flanked neomycin resistance cassette. (J:259583)